Biomedical Business Resources LLC is a network of experts in the Medical Device Industry. With over 35 years of industry experience, their services include:
Advisory - helping clients with strategy, operations, execution, and business building
Expert Witness - assisting attorneys with multiple expert reports, depositions, and testimony at trial and arbitration. Cases include disputes about intellectual property , product liability, and commercial contracts
Board Services - offering Independent Board Member services of medical device companies, public or private, with experience in building companies, and helping management teams in times of high growth and rapid change
Principal, Peter A. Crosby, has over 35 years of experience bringing multiple products to the world market from concept to market release. Mr. Crosby has been CEO of six medical device companies (public and private) in four countries, and member of the Board (including Chairman of the Board) of ten companies. His experience includes company formation, capital raising, product research and development, manufacturing, quality management systems, market launch, and sales management. With over 30 US patents and applications, he has managed the intellectual property portfolio of multiple companies.
Mr. Crosby's product experience includes implantable devices (cochlear implants, cardiac pacemakers, implantable defibrillators, artificial heart, neurostiumulation), in vitro diagnostics, imaging (ultrasound and X-ray), software, AEDs, and patient monitoring. His clinical domain experience includes ophthalmology, otolaryngology, cardiac surgery, cardiology, orthopedics, pain management, anesthesia and intensive care.
Imagine this scenario: Early stage company Smallco develops an exciting new technology, which it uses to create the prototype of its first product - Brakethroo! A large company in the same field, Bigco, becomes aware of Brakethroo, and realizes that if the product works as hoped, it could be a valuable addition to Bigco's product range. Bigco offers to buy the technology and product from the shareholders of Smallco. The merger and acquisition (M&A) agreement specifies an up-front payment, and one or more payments dependent on achievement of milestones. Bigco agrees to use "commercially reasonable efforts" to achieve the milestones. Smallco and Bigco sign the agreement, the shareholders of Smallco get an immediate payout and look forward to further milestone payments.